Quarterly report pursuant to Section 13 or 15(d)

Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details)

v3.23.1
Spin-off of OmniAb - Schedule of revenue and expenses of the discontinued operations (Details) - Discontinued operations
$ in Thousands
 3 Months Ended
Mar. 31, 2022
USD ($)
Revenues:  
Total revenues $ 9,177
Operating costs and expenses:  
Amortization of intangibles 3,233
Research and development 11,128
General and administrative 6,255
Total operating costs and expenses 20,616
Loss from operations (11,439)
Other income (expense):  
Other income, net 443
Total other expense, net 443
Loss before income tax (10,996)
Income tax benefit 8,540
Net loss (2,456)
Kyprolis  
Revenues:  
Total revenues 263
Contract revenue  
Revenues:  
Total revenues $ 8,914